Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
Trichostatin A may reduce OR52N1 expression by tightening chromatin structure around its promoter region, thus hindering access for transcriptional machinery. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
As a cytidine analog, 5-Azacytidine could decrease OR52N1 expression by causing DNA demethylation, which can disrupt transcriptional control mechanisms at the gene's promoter. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Actinomycin D may inhibit OR52N1 expression by intercalating into DNA, blocking RNA polymerase movement and subsequent transcription of the gene. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
Mithramycin A can downregulate OR52N1 expression by binding to its promoter DNA sequences and obstructing the binding of essential transcription factors. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $42.00 $185.00 $310.00 $650.00 | 6 | |
DRB might decrease OR52N1 expression by selectively inhibiting the transcription elongation process, which is critical for the synthesis of the full-length OR52N1 mRNA. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $57.00 $182.00 $92.00 | 21 | |
By inhibiting topoisomerase I, Camptothecin could lead to DNA damage responses that decrease OR52N1 expression by triggering cell cycle arrest or activating DNA repair pathways. | ||||||
Oxamflatin | 151720-43-3 | sc-205960 sc-205960A | 1 mg 5 mg | $148.00 $461.00 | 4 | |
Oxamflatin may downregulate OR52N1 by preventing histone deacetylation, which could result in less accessible chromatin for genes like OR52N1, thereby reducing their expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $260.00 $1029.00 | 26 | |
α-Amanitin could inhibit OR52N1 expression by targeting RNA polymerase II and preventing the elongation of OR52N1 mRNA transcripts, leading to reduced mRNA abundance. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin (Sirolimus) could decrease OR52N1 protein levels by inhibiting mTOR, a pathway that promotes protein synthesis, including the translation of OR52N1 mRNA. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $226.00 $846.00 | 1 | |
JQ1 might downregulate OR52N1 by inhibiting BRD4, a member of the BET bromodomain family, which normally enhances transcription of certain genes. | ||||||